- Home
- SKYE vs SND Comparison
SKYE vs SND Comparison
Compare SKYE & SND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- SND
- Stock Information
- Founded
- SKYE 2012
- SND 2011
- Country
- SKYE United States
- SND United States
- Employees
- SKYE N/A
- SND N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- SKYE Health Care
- SND Industrials
- Exchange
- SKYE Nasdaq
- SND Nasdaq
- Market Cap
- SKYE 80.7M
- SND 75.4M
- IPO Year
- SKYE N/A
- SND 2016
- Fundamental
- Price
- SKYE $1.44
- SND $2.06
- Analyst Decision
- SKYE Buy
- SND Hold
- Analyst Count
- SKYE 6
- SND 2
- Target Price
- SKYE $16.60
- SND $2.63
- AVG Volume (30 Days)
- SKYE 1.7M
- SND 282.5K
- Earning Date
- SKYE 05-09-2025
- SND 05-12-2025
- Dividend Yield
- SKYE N/A
- SND 4.87%
- EPS Growth
- SKYE N/A
- SND N/A
- EPS
- SKYE N/A
- SND 0.08
- Revenue
- SKYE N/A
- SND $311,372,000.00
- Revenue This Year
- SKYE N/A
- SND N/A
- Revenue Next Year
- SKYE N/A
- SND N/A
- P/E Ratio
- SKYE N/A
- SND $26.72
- Revenue Growth
- SKYE N/A
- SND 5.20
- 52 Week Low
- SKYE $1.14
- SND $1.73
- 52 Week High
- SKYE $17.65
- SND $2.80
- Technical
- Relative Strength Index (RSI)
- SKYE 40.43
- SND 44.52
- Support Level
- SKYE $1.26
- SND $1.80
- Resistance Level
- SKYE $3.73
- SND $2.11
- Average True Range (ATR)
- SKYE 0.34
- SND 0.20
- MACD
- SKYE 0.04
- SND -0.03
- Stochastic Oscillator
- SKYE 11.40
- SND 31.71
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About SND Smart Sand Inc.
Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.